In today’s recent session, 3.68 million shares of the Incyte Corp. (NASDAQ:INCY) have been traded, and its beta is 0.73. Most recently the company’s share price was $57.14, and it changed around $4.08 or 7.70% from the last close, which brings the market valuation of the company to $12.83B. INCY at last check was trading at a discount to its 52-week high of $67.36, offering almost -17.89% off that amount. The share price’s 52-week low was $50.27, which indicates that the recent value has risen by an impressive 12.02% since then. We note from Incyte Corp.’s average daily trading volume that its 3-month average coming to 1.90 million.
Incyte Corp. stock received a consensus recommendation rating of Buy, based on a mean score of 1.96. If we narrow it down even further, the data shows that 0 out of 21 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 4 recommended INCY as a Hold, whereas 12 deemed it a Buy, and 0 rated it as Underweight. Incyte Corp. is expected to report earnings per share of $1.08 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Incyte Corp. (NASDAQ:INCY) trade information
Instantly INCY has been showing a green trend so far today with a performance of 7.70% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -8.99% year-to-date, but still up 5.67% over the last five days. On the other hand, Incyte Corp. (NASDAQ:INCY) is 6.12% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $85.64, which translates to bulls needing to increase their stock price by 33.28% from its current value. Analyst projections state that INCY is forecast to be at a low of $52 and a high of $136.
Incyte Corp. (INCY) estimates and forecasts
Incyte Corp. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 8.80 percent over the past six months and at a 22.73% annual growth rate that is well above the industry average of 12.90%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 9.10% in revenue this quarter, and will report an increase of 7.30% in the next quarter. The year-over-year growth rate is expected to be 10.60%, up from the previous year.
Consensus estimates provided by 16 financial analysts predict the company will bring in an average of $1.01 billion in revenue for the current quarter. 15 analysts expect Incyte Corp. to make $1.05 billion in revenue for the quarter ending Sep 2024. The company’s sales for the same quarters a year ago were $954.61 million and $963.63 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 5.70%. Forecasts for the next quarter put sales growth at 8.90%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 38.99%. Incyte Corp. earnings are expected to increase by 18.29% in 2024, but the outlook is positive 22.50% per year for the next five years.
